CD177 and cancer: When the TPA particle reaches the target cancer cells, the RGD4C ligands observed on the TPA pIII capsid will bind to the heterodimer αvβ3 or αvβ5 integrins, and cell surface receptors were overexpressed in most tumour types including HCC, but barely expressed in normal cells.